Clinical Trial Update: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for JP-1366 in non-erosive gastroesophageal reflux disease; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Gastroesophageal Reflux Disease

Drugs mentioned

• JP-1366

Snippet

Sponsor: Onconic Therapeutics Inc. | Conditions: Non-erosive Gastroesophageal Reflux Disease | Phase 3 | Status: NOT_YET_RECRUITING